Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Responsive Parenting Can Help Counter Childhood Obesity

Kids are more likely to maintain a healthy weight if their parents adopt a responsive style while they re babies and toddlers, a new study suggests. Children ha

More Children Accidentally Poisoned By Fentanyl

The number of children poisoned through exposure to fentanyl, a powerful synthetic opioid, has skyrocketed in recent years, researchers have reported. Fentanyl

Splash Your Way To Weight Loss Through Water Aerobics

Purposeful splishing and splashing can help you trim your waist size and drop excess pounds, a new evidence review has concluded. Water aerobics led to about 6

America's Well-To-Do Have Less Heart Disease Risk

Well-to-do and better-educated Americans have far lower rates of heart disease than the rest of the population, a new study says. The top 20 of high-income, col

USDA Disbands Two Key Food Safety Committees

Two key federal advisory committees on food safety have been shut down, raising concerns among food safety advocates. The move was part of a Trump administratio

Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

Vaxart, Inc. (Nasdaq VXRT) today announced the initiation of a Phase 1, open label, dose ranging clinical trial evaluating its second-generation oral norovirus

Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial

Arvinas, Inc. (Nasdaq ARVN) and Pfizer Inc. (NYSE PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluati

2017 to 2023 Saw Decline in Exclusive Cigarette Smoking, Rise in Vaping

Decreases in exclusive cigarette smoking and increases in exclusive electronic cigarette use were seen among U.S. adults from 2017 to 2023, according to researc

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

Biogen Inc. (Nasdaq BIIB) announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and safety of

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

Gilead Sciences, Inc. (Nasdaq GILD) today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapav

Popular Keywords